GLP-1 From Telehealth: Keeping Your Doctor in the Loop

There is a specific awkwardness to this. You asked, they declined, and you went elsewhere. Telling them now feels like announcing that you overruled them.

Most people in this position quietly say nothing. That is the understandable choice and it is the wrong one, for reasons that have nothing to do with anyone’s feelings.

The reason this matters more than it feels like it does

The sharpest example is surgery.

Multi-society guidance published in 2025 covers how GLP-1 medications should be handled before procedures. It moved away from blanket rules toward individual assessment, weighing things like whether you are still escalating your dose, how high the dose is, whether you use a weekly formulation, and whether you have current gastrointestinal symptoms. It also addresses reducing risk through measures such as a pre-procedure liquid diet and adjusted anesthesia planning rather than automatically stopping the medication.

Every one of those inputs is information your anesthesiologist needs and cannot get if nobody knows you take it. This applies to a colonoscopy or a dental procedure under sedation, not only to major surgery.

That is the clearest case, but it is not the only one.

Lab results read differently. If your weight, glucose, lipids, or liver enzymes move, a doctor who does not know why may investigate a change that has an obvious explanation.

Other prescriptions interact with what is happening. Blood pressure and diabetes medications in particular may need adjusting as weight comes down. Someone has to be watching the whole list, and that is usually your regular doctor rather than a telehealth prescriber.

Emergency care depends on your chart. If you turn up somewhere unable to give a history, what is in the record is what they work from.

Persistent vomiting means something different. A doctor who knows you are on a GLP-1 evaluates that presentation differently from one who does not.

Consider this scenario: someone three months into treatment through telehealth has a gallbladder issue and is scheduled for surgery. Their chart lists no GLP-1 because they never mentioned it. Nobody asks about weekly injections. The pre-procedure conversation that should have happened does not happen, because the information needed to start it was never in the room.

How to actually raise it

The tone that works is not confession and not defensiveness. You made a decision about your own care and you are keeping your physician informed, which is what a patient is supposed to do.

Something in the shape of: “I want to update my chart. I started semaglutide through a telehealth service in March. I know it wasn’t what you recommended, but I want it in my records and I’d like you to see the labs.”

Then give them the specifics, because a doctor cannot chart a vague statement:

• The exact medication and current dose
• Whether it is a branded product or compounded, and if compounded, which pharmacy prepares it
• When you started and your escalation schedule so far
• The prescribing service and provider name
• Any side effects you have had
• What has changed measurably

That last point is where having kept records helps. Our guide on tracking your progress covers what is worth writing down, and it turns out to be roughly what another clinician wants to see.

The pharmacy detail matters more than people expect. A physician evaluating a compounded product will want to know where it comes from, and “an online service” is not an answer. If you do not know, our guide on verifying a compounding pharmacy covers how to find out and what to look for. That is worth knowing for your own sake regardless of who else asks.

If they react badly

Some will. A few will be annoyed, and a few will say they cannot be responsible for monitoring a medication they did not prescribe.

That second position is reasonable and it is not a dismissal. You can say: “I’m not asking you to manage it. I’m asking you to have it in my chart and to tell me if you see something in my labs that concerns you.”

Most of the friction comes from an assumption that you are asking them to take on liability. Saying plainly that you are not usually defuses it.

If the conversation goes badly anyway, the information still needs to be in the record. Ask that it be documented even if they disagree with the decision. A chart is a factual account of what you take, not an endorsement.

And if your doctor’s objection was clinical rather than administrative, it is worth actually hearing it. They may know something about your history that a telehealth intake did not surface. That is not a reason to stop. It is a reason to ask them what specifically concerned them and to take the answer to your prescriber.

What good coordination looks like

At minimum: your regular doctor has the medication and dose in your chart, you mention it to any new clinician including dentists and specialists, you carry it on your medication list, and you tell your prescriber about anything your regular doctor finds.

Better than that: you get your routine labs through your regular doctor and share them with your prescribing service, so one set of results informs both. Most telehealth providers will accept outside labs, and it saves you duplicating them.

Our guide on getting the most out of your GLP-1 treatment covers the broader picture of what supports results, and having one clinician who sees your whole history is part of it.

The short version

Tell them, and tell them in writing so it lands in the chart. Lead with the update rather than the justification. Bring specifics: drug, dose, start date, pharmacy, prescriber, side effects, results. Make clear you are not asking them to take over management. And if they raise a clinical objection, take it seriously enough to put the question to the person who is prescribing.

The awkwardness lasts one conversation. A chart that does not list what you take follows you into every room you walk into.

If you want a prescribing service that expects to coordinate with your regular doctor rather than work around them, TrimRx includes ongoing provider access alongside treatment.

This information is for educational purposes and is not medical advice. Consult with a healthcare provider before starting any medication. Individual results may vary.